3 NSE Stocks Just Flipped to Strong Bullish
On July 29th, Ajanta Pharma, Exide Industries, and Glenmark Pharma shifted to Strong Bullish, signaling multi-timeframe momentum.
- Visit the stock pages: AJANTPHARM, EXIDEIND, GLENMARK
- Sector CNXPHARMA , which ranks #1 for Relative Strength (Altra Sector score of 95.0 with bullish regime.)
On July 29th, three prominent NSE stocks – Ajanta Pharmaceuticals, Exide Industries, and Glenmark Pharmaceuticals – demonstrated significant momentum shifts, transitioning from Neutral to Strong Bullish on the Altra Score. This cross-sector movement coincides with broader market breadth improvements, suggesting an environment where confirmed setups are gaining traction.
The Altra Score, a 0-100 momentum gauge, assesses a stock's strength using EMA alignment and RSI trends across daily, weekly, and monthly timeframes; a higher score means more bullish momentum. The Altra Market score reflects overall market breadth by tracking the percentage of stocks above key EMAs, while the Altra Sector score applies this analysis at the sector level, ranking its relative strength.
Currently, the Altra Market score is 62.7 ('Improving'). Breadth indicators are positive: 66.0% of stocks above their 20-day EMA, 60.0% above 50-day, and 52.0% above 200-day. An advance/decline ratio of 38/12 and a 15-day score trend of +16.6 further support positive sentiment. While market texture favors high-quality setups, these three stocks illustrate how robust momentum can emerge within such an environment.
Ajanta Pharmaceuticals (AJANTPHARM)
Ajanta Pharmaceuticals exhibited a notable surge, its Altra Score jumping from 55.3 (Neutral) to 88.1 (Strong Bullish) on July 29th. This significant shift places Ajanta in a strong momentum posture, reinforced by its sector leadership. The Nifty Pharma sector, where Ajanta operates, holds an impressive Altra Sector score of 95.0, ranking first and indicating a strongly bullish outlook. This sector is a confirmed leader and accelerating, evidenced by its Relative Strength RSI of 70.2.
Ajanta's individual metrics show consistent strength: daily RSI 55.22, weekly 67.07, and monthly 74.48, indicating broad-based upward price pressure. Its price action is positioned above all key EMAs, a classic sign of trend strength. A bullish Weekly EMA Crossover on December 19th, 2025, preceded this surge. 'Top-down alignment' confirms cohesive momentum across all timeframes, providing a robust picture of its current strength.
Exide Industries (EXIDEIND)
Exide Industries also made a strong momentum move, its Altra Score advancing from 59.6 (Neutral) to 87.7 (Strong Bullish) on July 29th. This robust shift aligns with an improving outlook for auto-related sectors. The Nifty Auto sector, including Exide, holds a solid Altra Sector score of 71.0, placing it second and firmly in a bullish regime. This sector is also a confirmed leader and accelerating, with its Relative Strength RSI at 62.7.
Exide's momentum is reflected in its RSI readings: 60.15 daily, 68.78 weekly, and 65.66 monthly, indicating sustained buying interest. The stock's price is above its key EMAs, signaling technical strength. An earlier bullish Weekly EMA Crossover on May 29th, 2026, laid groundwork for this momentum expansion. The 'top-down alignment' further solidifies its bullish momentum consistency across daily, weekly, and monthly views, making its shift to Strong Bullish particularly compelling.
Glenmark Pharmaceuticals (GLENMARK)
Rounding out this trio is Glenmark Pharmaceuticals, which saw the most dramatic increase in its Altra Score, rocketing from 43.1 (Neutral) to an impressive 91.1 (Strong Bullish) on July 29th. This substantial leap firmly establishes Glenmark's strong upward momentum. Like Ajanta, Glenmark benefits from its top-ranked Nifty Pharma sector, with an Altra Sector score of 95.0. This sector's 'Confirmed leader, accelerating' status, supported by an RS RSI of 70.2, provides a powerful tailwind.
Glenmark's individual momentum metrics paint a clear picture. Its daily RSI is 55.54, weekly 56.25, and monthly 69.36. While the weekly RSI is slightly lower, the overall trend remains positive, especially against its strong monthly RSI. Crucially, Glenmark's price trades above all its key EMAs, indicating a healthy uptrend. A bullish Weekly EMA Crossover was identified earlier on June 6th, 2025, suggesting a long-term shift now manifesting in higher momentum scores. The 'top-down aligned' status further confirms cohesive and robust momentum across different timeframes.
The concurrent shift of Ajanta Pharmaceuticals, Exide Industries, and Glenmark Pharmaceuticals into the Strong Bullish category on the Altra Score highlights building conviction across market segments. These moves, particularly within high-performing sectors like Pharma and Auto, underscore the importance of identifying robust, multi-timeframe momentum setups. As the Altra Market score signals improving breadth while advising selectivity, these examples demonstrate how data-driven insights can pinpoint areas of significant technical strength.
What is the Altra Score? The Altra Score is AltraOne's proprietary momentum score for individual stocks, ranging from 0 to 100. It measures EMA structure and RSI momentum across multiple timeframes. A score above 60 is Bullish, below 40 is Bearish, and 40–60 is Neutral. The score is updated every trading day after market close based on end-of-day data.
Explore the full Signal History on AltraOne to see every EMA crossover signal across your watchlist — going back 52 weeks. The weekly EMA crossover is AltraOne's highest-conviction intermediate momentum signal; the Signal History page lets you track how these have played out over time.
Altra Score is a momentum indicator reflecting EMA alignment and RSI trend across daily, weekly, and monthly timeframes. It is not investment advice. Past momentum does not guarantee future performance. Please consult a SEBI-registered advisor before making investment decisions.